glp-1 pregnancy news today Taking GLP-1s during the first trimester of does not appear to substantially increase the risk of adverse outcomes GLP-1 receptor agonist exposure linked

Cardiovascular and Renal Effects of the Combination Therapy of a GLP-1 Receptor Agonist and an SGLT2 Inhibitor in Observational Real-Life Studies

If pancreatitis is suspected, Wegovy should be discontinued and appropriate diagnostic tests performed urgently Gallbladder problems : Rapid weight loss increases risk of gallstone formation, with cholelithiasis reported in approximately 1.6% of Wegovy users Intestinal obstruction/ileus : Cases have been reported in post-marketing surveillance, particularly in patients with pre-existing GI conditions Management strategies recommended by healthcare professionals include: Eating smaller, more frequent meals rather than large portions Avoiding high-fat, spicy, or heavily processed foods Staying well-hydrated, particularly if experiencing diarrhoea or vomiting, to prevent dehydration and potential acute kidney injury Not lying down immediately after eating to minimise reflux Ensuring adequate fibre intake to prevent constipation Taking the medication on the same day each week to maintain steady levels Most GI side effects improve over time as the body adjusts to the medication, typically becoming less troublesome after 4-8 weeks at each dose level

Comprehensive Weight Loss Treatments for Women Over 40 Women over 40 face unique challenges when it comes to weight management, often influenced by hormonal changes, menopause, and slowing metabolism

Comput Methods Programs Biomed